Health Care Supplies

Morgan Keegan has downgraded its rating on Haemonetics Corp.(NYSE: HAE) in light of the company's current upside. According to Morgan Keegan, “We are changing our rating on Haemonetics to Market Perform from Outperform. The change in rating is driven by our view that there is greater appreciation...

Benchmark made a number of rating and price target updates in a research report published today. CryoLife (NYSE: CRY) had its rating upgraded from Hold to Buy. Its price target was maintained at $6.50. On Thursday, CRY lost 1.99% of its value to finish the day at $5.42. Expedia (NASDAQ: EXPE)...

Haemonetics Corporation (NYSE: HAE) was downgraded by Morgan Keegan from "outperform" to "market perform." HAE's shares closed at $65.18 yesterday. Haemonetics' trailing-twelve-month ROA is 8.65%. Robert W. Baird downgraded Constant Contact Inc (NASDAQ: CTCT) from “outperform” to “neutral.” CTCT's...

Morgan Keegan has downgraded Haemonetics Corporation (NYSE: HAE) from Outperform to Market Perform with a $76 price target.

Shares of Immucor (NASDAQ: BLUD) are higher on the session by 0.13%, currently trading at $26.91. The stock has been moving largely higher over the past six weekss and is currently trading above the 50-day moving average. Options traders are buying puts on the name today. A short while ago the...

Analysts at Jefferies & Company downgraded El Paso Electric Company (NYSE: EE) from “buy” to “hold.” EE's stock closed at $33.17 yesterday. El Paso Electric's PEG ratio is 2.93. Analysts at Nomura downgraded CNOOC Limited (NYSE: CEO) from “buy” to “neutral.” CNOOC's shares closed at $234.81...

Roth Capital has downgraded Uroplasty (NASDAQ: UPI) from Buy to Neutral.

Stocks trading at or near 52-week highs and lows provide excellent trading opportunities, as volatility tends to increase at such levels. The following stocks hit new 52-week highs in Tuesday's trading session (listed from highest total volume to lowest): 1) Apple (NASDAQ: AAPL): Shares of Apple...

When Steve Jobs revealed this past January that he was taking his second medical leave as CEO of Apple in less than five years, we all knew things were very uncertain at Apple. We didn't know how long the medical leave would last, or even if Jobs would be back as CEO of the company he founded 35...

ICU Medical (Nasdaq: ICUI) is raising the bottom end of its previously announced revenue guidance range. The new range is $297 million to $305 million, compared to its previous range of $295 million to $305 million. Based on the current business trends, management is also raising the bottom end...

It's time to get ready for Danaher (NYSE: DHR) earnings! Don't be caught off-guard: The company releases its next round of earnings this Thursday, July 21, 2011. Want to get all the facts ahead of this Thursday's announcement? We thought so. Here's an advanced look at Danaher's second quarter...

Accelerates Endologix's Transition to Direct Sales in Europe Supports LeMaitre's Strategy to Focus on Core Vascular Products Endologix, Inc. (Nasdaq: ELGX) and LeMaitre Vascular, Inc. (Nasdaq: LMAT) announced today that the companies have entered into an early termination agreement for LeMaitre's...

Immucor, Inc. (Nasdaq: BLUD) and IVD Acquisition Corporation, an affiliate of TPG Capital, L.P., today announced that IVD Acquisition Corporation has commenced the previously-announced tender offer for all of the outstanding shares of common stock of Immucor at a price of $27.00 per share, in cash...

The Cooper Companies, Inc. (NYSE: COO) today announced that consistent with the plan approved by its board of directors to pay annual dividends, the Company declared a semi-annual dividend of 3 cents per share, payable on August 5, 2011, to stockholders of record on July 25, 2011.

Stocks trading at or near 52-week highs and lows provide excellent trading opportunities, as volatility tends to increase at such levels. The following stocks hit new 52-week highs in Tuesday's trading session (listed from highest total volume to lowest): 1) Adventrx Pharmaceuticals (NYSE: ANX...